Corcept Therapeutics
Founded in 1998, Corcept focuses on field in the research and development of selective glucocorticoid receptor antagonists. Corcept is headquartered in Menlo Park, California.
Last updated on
About Corcept Therapeutics
Founded
1998Estimated Revenue
$250M-$500MEmployees
51-250Funding / Mkt. Cap
$119MCategory
Sector
Health CareIndustry Group
Pharmaceuticals, Biotechnology & Life SciencesIndustry
BiotechnologyLocation
City
Menlo ParkState
CaliforniaCountry
United StatesTech Stack (98)
